TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,478,948 | +22.7% | 223,542 | -21.3% | 0.03% | +14.8% |
| Q1 2023 | $6,908,874 | -14.8% | 284,082 | +1.7% | 0.03% | -12.9% |
| Q4 2022 | $8,113,253 | +13.5% | 279,382 | +17.1% | 0.03% | 0.0% |
| Q3 2022 | $7,151,000 | -10.3% | 238,512 | +8.2% | 0.03% | -3.1% |
| Q2 2022 | $7,973,000 | -3.9% | 220,492 | +14.9% | 0.03% | +23.1% |
| Q1 2022 | $8,298,000 | +5.5% | 191,820 | +22.2% | 0.03% | +4.0% |
| Q4 2021 | $7,869,000 | -8.6% | 157,025 | +16.0% | 0.02% | -10.7% |
| Q3 2021 | $8,613,000 | -6.4% | 135,355 | +5.8% | 0.03% | 0.0% |
| Q2 2021 | $9,203,000 | +13.9% | 127,885 | +16.7% | 0.03% | +12.0% |
| Q1 2021 | $8,079,000 | +9.0% | 109,545 | +8.5% | 0.02% | -3.8% |
| Q4 2020 | $7,415,000 | +60.6% | 100,990 | +19.9% | 0.03% | +23.8% |
| Q3 2020 | $4,618,000 | +3.3% | 84,200 | +25.2% | 0.02% | 0.0% |
| Q2 2020 | $4,471,000 | +2.1% | 67,250 | -6.0% | 0.02% | -16.0% |
| Q1 2020 | $4,377,000 | -34.7% | 71,520 | -6.2% | 0.02% | +8.7% |
| Q4 2019 | $6,701,000 | +32.6% | 76,210 | +13.7% | 0.02% | +15.0% |
| Q3 2019 | $5,055,000 | -7.5% | 67,000 | +4.8% | 0.02% | -4.8% |
| Q2 2019 | $5,463,000 | -11.8% | 63,950 | +11.5% | 0.02% | -12.5% |
| Q1 2019 | $6,197,000 | -71.9% | 57,330 | -62.1% | 0.02% | -74.5% |
| Q2 2016 | $22,034,000 | +3.2% | 151,330 | +1.6% | 0.09% | +4.4% |
| Q1 2016 | $21,342,000 | +1.0% | 148,983 | +9.0% | 0.09% | +4.7% |
| Q4 2015 | $21,132,000 | +13.0% | 136,733 | +4.4% | 0.09% | +14.7% |
| Q3 2015 | $18,708,000 | -6.3% | 130,924 | -5.8% | 0.08% | +7.1% |
| Q2 2015 | $19,965,000 | -31.7% | 138,944 | -32.9% | 0.07% | -31.4% |
| Q1 2015 | $29,215,000 | -6.8% | 207,158 | -2.1% | 0.10% | -6.4% |
| Q4 2014 | $31,342,000 | -25.9% | 211,499 | -23.1% | 0.11% | -28.8% |
| Q3 2014 | $42,321,000 | -40.9% | 275,064 | -46.2% | 0.15% | -39.5% |
| Q2 2014 | $71,656,000 | +41.8% | 510,952 | +12.2% | 0.25% | +35.3% |
| Q1 2014 | $50,533,000 | -3.6% | 455,252 | -14.1% | 0.19% | -16.5% |
| Q4 2013 | $52,411,000 | +57.2% | 529,936 | +20.8% | 0.22% | +46.4% |
| Q3 2013 | $33,339,000 | – | 438,675 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |